MENU
+Compare
RAFA
Stock ticker: OTC
AS OF
Jan 14 closing price
Price
$0.04
Change
+$0.01 (+33.33%)
Capitalization
3.07M

RAFA Rafarma Pharmaceuticals, Inc. (WY) Forecast, Technical & Fundamental Analysis

Rafarma Pharmaceuticals Inc is engaged in pharmaceuticals and has several subsidiaries specializing in developing and producing medical equipment, as well as supplying equipment for hospitals and clinics from Germany, China, Slovakia, and others... Show more

RAFA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for RAFA with price predictions
Jan 14, 2026

RAFA in upward trend: price expected to rise as it breaks its lower Bollinger Band on December 31, 2025

RAFA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 44 cases where RAFA's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for RAFA just turned positive on January 12, 2026. Looking at past instances where RAFA's MACD turned positive, the stock continued to rise in of 56 cases over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where RAFA advanced for three days, in of 155 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Momentum Indicator moved below the 0 level on January 07, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on RAFA as a result. In of 110 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

RAFA moved below its 50-day moving average on December 31, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for RAFA crossed bearishly below the 50-day moving average on December 19, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RAFA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for RAFA entered a downward trend on December 23, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. RAFA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (29.698). P/E Ratio (0.000) is within average values for comparable stocks, (76.061). RAFA's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.042). RAFA has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.030). P/S Ratio (0.000) is also within normal values, averaging (72.584).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RAFA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

View a ticker or compare two or three
RAFA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
N/A
Address
12465 Sourth Fort Street
Phone
+1 307 429-2029
Employees
N/A
Web
https://www.rafarma.si
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NUS11.020.39
+3.67%
NuSkin Enterprises
CTOR1.100.01
+0.92%
Citius Oncology Inc
FA14.860.06
+0.41%
First Advantage Corp
AGMH1.99N/A
N/A
AGM Group Holdings Inc
RTO31.09-0.34
-1.08%
Rentokil Initial plc

RAFA and Stocks

Correlation & Price change

A.I.dvisor tells us that RAFA and SFOSF have been poorly correlated (+9% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RAFA and SFOSF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RAFA
1D Price
Change %
RAFA100%
+2.94%
SFOSF - RAFA
9%
Poorly correlated
N/A
OWPC - RAFA
7%
Poorly correlated
N/A
SBFM - RAFA
6%
Poorly correlated
N/A
TCNNF - RAFA
5%
Poorly correlated
+2.18%
OMID - RAFA
3%
Poorly correlated
N/A
More

Groups containing RAFA

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RAFA
1D Price
Change %
RAFA100%
+2.94%
Pharmaceuticals: Generic
industry (218 stocks)
1%
Poorly correlated
+0.49%